Explore our product offering by market:
We are a world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications.
![scientist in lab looking at a slide](/mediaassets/images/health-care/health-care-new-website/curated-cards/curated-card-1.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=DA088D103276F4F268DE35C0423FFB6A)
Human pharmaceuticals
We specialise in developing the highest quality and purest grades of pharmaceutical excipients, lipids and vaccine adjuvants to help you formulate seamlessly and drive your products to market. We tailor excipient purity to your needs. We are committed to product quality, regulatory excellence, and supply chain security. We have worked with many pharma companies to bring COVID-19 vaccines and treatments to market faster, using our adjuvant and Super Refined™ excipients. While continuing to invest in expanding our portfolio and manufacturing footprint globally, quality is at the forefront of our plans.
![Cow and dog in field with blue wash over image](/mediaassets/images/health-care/health-care-new-website/curated-cards/veterinary-curated-card.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=3451299235632F463D09FA682EFBED0D)
Veterinary health
To serve the growing veterinary health market, we develop and commercialise a wide range of specialty excipients which are used to enhance the delivery, efficacy, and stability of actives in livestock and companion animal health products. Our broad portfolio also comprises adjuvants for the important veterinary vaccine market and extends further to omega-3 essential fatty acids for pet food products. We collaborate with your formulation scientists to produce safer, more efficient, and highly specialised products that are used across a variety of marketed veterinary dosage forms. We strive to offer innovative solutions to meet the challenges formulators, veterinarians and livestock producers face every day.
Explore recent blogs:
![manufacturing pd](/mediaassets/images/health-care/untitled-design-(27).png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A3F1E1F41A1C690A537D793D09D9F2EA)
QbD Formulation Development
Formulation development is a pivotal stage in the life cycle of a therapeutic drug product, it can be the make or break of it. The goal of formulation development is to convert active substance (drug...
![green washed depiction of an LNP](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/shutterstock-1168651498-nad-filter-(1).jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A303EDE921EF0283547DD585579EDC71)
Targeted lipid nanoparticles in Nucleic Acid Delivery
Targeted lipid nanoparticles (tLNPs) enhance the precision and efficacy of delivering a variety of therapeutic agents including nucleic acids to specific tissues and cell populations, thereby...
![Blue washed image of female in the lab](/mediaassets/images/health-care/health-care-new-website/blog-and-news-area/cgt-catapult/cgt-catapult.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=FD80FE8775220501CB70AA34825AF10C)
Croda joins CGT Catapult consortium to improve AAV formulation
The Cell and Gene Therapy Catapult (CGT Catapult) has established a cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation.
![man in a lab looking at results](/mediaassets/images/health-care/health-care-new-website/feature-cards/protein-delivery-images.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=5A392E7262B182914859020F0BB30CCF)
Synthesis, characterisation and degradation of polysorbates in biopharmaceuticals
Polysorbates are essential in biologics delivery, serving as crucial emulsifiers and stabilisers for biopharmaceuticals. They enhance solubility, improve bioavailability, and protect proteins from...